What’s up, Doc?
Federal Regulations Pose New Challenges to Natural Product Access
constellation of recent activity from federal agencies raises new questions about potential restrictions on consumer and practitioner access to natural products. The first three initiatives below are from the Food and Drug Administration (FDA), historically viewed as an adversary by many users of dietary supplements and other natural health products. The fourth is from the Drug Enforcement Administration (DEA).
Homeopathic Teething Agents as well as mortalities. Was there an errant manufacturer selling product as a low-potency homeopathic that could make it harmful? Was a mix of some agent like belladonna improperly potentiated by a manufacturer? Or is the campaign a gratuitous assault on the industry, as some believe? At the time of writing this column, representatives of the National Center for Homeopathy shared that they anticipate filing a Freedom of Information Act request to learn more about what provoked the FDA action.
New Dietary Ingredients His organization estimates that the FDA’s guidance will produce between $377 million and $5 billion per year in additional costs to manufacturers, and thus, to consumers. Natural products consultant Michael Levin of Health Business Strategies has been organizing practitioners and their organizations to be heard on the topic. Israelsen’s organization has been the most outspoken on the topic among the natural products industry organizations.
Access to Natural Agents from Compounding Pharmacies